Picture courtesy India TV
New Delhi: The government aims to boost domestic vaccine production by booking 30 crore doses of Hyderabad-based Biological-E’s Covid jabs.
The Health Ministry will make an advance payment of Rs 1,500 crore to the company for this purpose.
The new vaccine, which is still in clinical trials, will be the second made-in-India vaccine to be used in the country after Bharat Biotech’s Covaxin, NDTV reported.
According to a government statement, the doses will be manufactured and stockpiled by Biological-E from August to December and are likely to be available “in the next few months”.
The new vaccine arrangement is “part of the wider endeavour of the government to encourage indigenous vaccine manufacturers” by providing them support in research and development and costs, the statement added.
Biological-E’s vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2.
Current Vaccine Status
Besides Covaxin and Serum Institute of India’s Covishield, Russia’s Sputnik V will soon be used to vaccinate people as the government races towards a target of daily one crore vaccinations by August.
It is also in talks with foreign makers like Pfizer and Moderna, who have insisted on an indemnity clause.
Also Read: Serum Institute Seeks Legal Shield Against Vaccine Side Effects
Bhubaneswar: The Commissionerate Police have issued traffic advisory in view of the state-level Republic Day 2025…
Bhubaneswar: The Odisha government has decided to provide Rs 5 lakh as seed money to…
Bhubaneswar: The Odisha government has increased the charges of the transport agents engaged in supply…
Mumbai: Actor Karan Veer Mehra, who bagged the trophy of Bigg Boss 18 on Sunday,…
Mumbai: Ahead of the ‘Bigg Boss 18’ grand finale, reports suggested that Akshay Kumar and…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Tuesday announced 50% increase in monthly remuneration…
This website uses cookies.
